1. FDA Targets 2,200+ Firms Over Missing Clinical Trial Results, Warns of Fines
The FDA is escalating pressure on the pharmaceutical and research sectors, sending formal reminder letters to over 2,200 companies and researchers demanding compliance with federal clinical trial reporting laws. The agency's internal analysis revealed a significant gap: results were missing for nearly 30% of studies de...